Physician profile
Eduardo Egea
NPI 1346567914
$16,953.26
in general payments reported to CMS, 2019-2025
43 companies · $1,451 in 2025
The $1,451 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,584 · 2020: $1,174 · 2021: $1,327 · 2022: $1,461 · 2023: $1,528 · 2024: $8,428 · 2025: $1,451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,587 · Food and Beverage: $4,739 · Travel and Lodging: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,586.80 |
| Food and Beverage | $4,739.48 |
| Travel and Lodging | $1,080.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,838.07 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $1,719.02 | 2019-2025 | Tezspire, Fasenra, Breztri |
| Glaxosmithkline, LLC. | $1,648.27 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,124.32 | 2019-2025 | Ofev, Stiolto Respimat |
| Mallinckrodt Hospital Products INC. | $661.37 | 2021-2025 | Acthar |
| Genzyme Corporation | $482.32 | 2019-2025 | |
| Grifols USA, LLC | $455.13 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $391.19 | 2021-2025 | Smartvest |
| Mylan Specialty L.P. | $362.16 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $317.72 | 2019-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $312.96 | 2020-2025 | Glassia |
| Amgen INC. | $298.91 | 2021-2025 | Tezspire |
| Philips North America LLC | $291.95 | 2019-2022 | |
| Insmed, INC. | $262.75 | 2020-2024 | Arikayce |
| Baxter Healthcare | $221.66 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Egea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.